Abstract:Objectives: The Brazilian Unified Health System (Sistema Único de Saúde-SUS) is the universal public healthcare system of Brazil that maintains a nationwide database of its patients. Our primary objective was to analyze regional and temporal trends, while our secondary goal was to establish correlations between states' health economy status and their prostate cancer (PCa) epidemiology. Methods: We analyzed Brazil's nationwide data on prostate cancer (PCa) incidence, mortality, and care gathered between 2013 and 2021 by the Information Technology Department of SUS (DATA-SUS), updated monthly using the International Classification of Diseases (ICD-10) code. Results: In the period, 273,933 new cases of PCa and 135,336 PCa deaths were reported in men aged 50 years or over in Brazil. The median annual PCa-specific incidence rate (PCSIR) ranged from 14.7 in the Southeast to 6.9 in the North region and the median annual PCa-specific mortality rate (PCSMR) ranged from 7.7 in the Northeast to 6.0 in the South region (per 10,000 men >50). The median annual mortality to incidence ratio (MIR) was highest in the North (0.88) and lowest in the Southeast region (0.44). There were significant regional differences in PCa treatment rates (per new cases); the Midwest region had the highest median annual surgery rate (0.63) while the North region had the highest median annual systemic therapy rate (0.75) and the lowest radiation therapy rate (0.06). Temporal analysis of the data showed significant change in annual rate trends after the year 2018 for PCSIR (coefficient [β] = +3.66, p < 0.001), any treatment (β = -0.06, p = 0.016), surgery ([SR] β = +0.05, p = 0.017) radiation therapy ([RTR] β = -0.06, p = 0.005) and systemic therapy ([STR] β = -0.10, p = 0.002). After the 2020 pandemic, annual PCSIR decreased (β = -2.15, p = 0.002) but annual PCSMR, MIR, and treatment rates remained stable. Correlation studies showed that the PCSIR was strongly negatively correlated with STR (p < 0.001) and positively correlated with RTR (p = 0.004). MIR was positively correlated with STR (p < 0.001) and negatively correlated with the number of robotic surgical systems per million population (p = 0.003). Conclusion: Our data shows that PCa care is dependent on the region and is likely influenced by access to treatment options. Furthermore, changes after the year 2018 underscore the influence of international guidelines on Brazilian clinicians' decision-making especially concerning population screening which in turn affected incidence and treatment rates. Limitation of our study includes limited patient-related information and data on private practices as well as an unknown impact of traveling patients.

Relationship between universal health insurance benefits and prostate cancer mortality in Colombia

Impact of the universal health insurance benefits on cervical cancer mortality in Colombia

Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis

The Impact of Health Inequities on Population-Based Breast Cancer Survival in a Colombian Population, 2008-2015

Cancer epidemiology in Cali, 60 years of experience

Prognosis impact and clinical findings in renal cancer patients: comparative analysis between public and private health coverage in a cross-sectional and multicenter context

Characterization of the population affiliated to the subsidized health insurance scheme in Colombia: a systematic review and meta-analysis

Cancer mortality among Colombian and foreign populations over a 15-year period

Migration and cancer mortality among Colombian migrants in the USA: a death certification study

Socioeconomic inequalities of 3-year survival in formal employees with colorectal cancer between 2012 and 2019 in Colombia

Semiparametric Modelling of Cancer Mortality Trends in Colombia

Prostate cancer temporal and regional trends in Brazil

Study on the concentration, distribution, and persistence of health spending for the contributory scheme in Colombia

The Effect of Community-Based Health Insurance on the Utilization of Modern Health Care Services: Evidence from Burkina Faso

Managed competition in Colombia: convergence of public and private insurance and delivery

Barriers of access to care in a managed competition model: lessons from Colombia

Loss ratio of the capitation payment unit of the health-promoting entities in Colombia between 2017 and 2021: a financial-actuarial approach

Supplementary Health Insurance in the Colombian Managed Care System: Adverse or Advantageous Selection?

Barriers to adherence to cytology exam: a case study in low-income Colombian women

Trends in prostate cancer incidence and mortality to monitor control policies in a northeastern Brazilian state

Hospitalization and mortality rates of malignant prostatic neoplasms in Brazil: A cross-sectional study from 2008 to 2018